EXOZ - NASDAQ
eXoZymes, Inc.
$9.41
-0.53%eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
At a Glance
Live Snapshotexoz
Total Liabilities and Equity
Last Annual Value
5.97M
3-Year CAGR
31%
5-Year CAGR
21%
10-Year CAGR
10%
eXoZymes, Inc. Competitors Analysis of Total Liabilities and Equity
| Company | Total Liabilities and Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
 eXoZymes, Inc. NASDAQ:EXOZ | 5.97M | 18.8% | 20.5% | N/A | |
 aTyr Pharma, Inc. NASDAQ:ATYR | 94.16M | -7.9% | -4.0% | 1.6% | |
 MacroGenics, Inc. NASDAQ:MGNX | 256.85M | -4.9% | -5.2% | -1.9% | |
 Metagenomi, Inc. Common Stock NASDAQ:MGX | 221.10M | -15.4% | 9.3% | N/A | |
 Zentalis Pharmaceuticals, Inc. NASDAQ:ZNTL | 288.97M | -19.9% | -9.3% | N/A | |
 Quince Therapeutics, Inc. NASDAQ:QNCX | 114.48M | -14.0% | -3.0% | N/A | |
 Atossa Therapeutics, Inc. NASDAQ:ATOS | 47.61M | -20.9% | -19.5% | 27.7% | |
 Anebulo Pharmaceuticals, Inc. NASDAQ:ANEB | 12.15M | 1.3% | -10.9% | N/A | |
 Instil Bio, Inc. NASDAQ:TIL | 203.52M | -14.5% | -19.7% | N/A | |
 Greenwich LifeSciences, Inc. NASDAQ:GLSI | 3.81M | -18.4% | -32.5% | N/A | |
 Tevogen Bio Holdings Inc. NASDAQ:TVGN | 3.46M | -14.3% | -14.7% | N/A |
eXoZymes, Inc. Fair Value Envelope
Related Guides
Continue your EXOZ research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.